Bal Pharma Ltd. - Research Center
524824 BALPHARMA Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | Mar' 22 | |
|---|---|---|---|---|---|
| Sales | 81.97 | 76.56 | 75.05 | 69.51 | 73.76 |
| Operating profit | 8.27 | 6.30 | 6.01 | 5.44 | 3.48 |
| Interest | 3.84 | 3.12 | 2.83 | 2.37 | 2.45 |
| Gross profit | 4.87 | 3.96 | 3.56 | 3.64 | 4.98 |
| EPS (Rs) | 1.35 | 0.94 | 0.72 | 0.90 | 1.87 |
Quarterly
results in details
| Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | Mar' 22 | |
|---|---|---|---|---|---|
| Other income | 0.44 | 0.77 | 0.38 | 0.56 | 3.94 |
| Stock adjustment | -9.60 | 0.47 | -5.72 | -3.05 | 3.39 |
| Raw material | 49.72 | 38.89 | 45.05 | 42.79 | 41.09 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 13.70 | 13.21 | 13.45 | 11.56 | 12.23 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 19.89 | 17.69 | 16.27 | 12.76 | 13.56 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.66 | 2.03 | 1.96 | 1.83 | 2.11 |
| Taxation | 1.09 | 0.46 | 0.47 | 0.40 | 0.09 |
| Net profit / loss | 2.12 | 1.47 | 1.13 | 1.41 | 2.77 |
| Extra ordinary item | - | - | - | - | -0.01 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 15.69 | 15.69 | 15.57 | 15.57 | 14.82 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 10.09 | 8.23 | 8.01 | 7.83 | 4.72 |
| GPM (%) | 5.91 | 5.12 | 4.72 | 5.19 | 6.41 |
| NPM (%) | 2.57 | 1.90 | 1.49 | 2.01 | 3.57 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis